|Subscribe Our Newsletters|
Asia’s biopharma industry is growing, and growing fast. With technical expertise, low manufacturing costs and improving regulatory frameworks, its value will soon run into the hundreds of billions of dollars. Are you making the most of the opportunity?
From humble beginnings as BioMedical Asia in 2008, BioPharma Asia 2017 has attracted close to 20,000 attendees over the last 8 years. Established as a true one-stop shop for all things biopharma, our 2017 program will be bigger than ever before, allowing you to explore innovation in clinical trials, manufacturing, supply chain, market access, partnering, pricing, vaccines & infectious diseases, antibodies, orphan drugs, biosimilars, stem cells and more.
Over 120 C-Level executives will share case studies from across the world, ensuring you can learn from the best of the best, then you can spend time debating with them during the small-group roundtable sessions, so you have time to foster relationships and make new business contacts.
Whether you’re operating in Asia already and just want to stay abreast of the latest industry innovation, or planning to launch into the Asian market, you need to join us as we lay the foundations for Asia’s biopharma future.
Quote AKRW for 15% discount off current prices!